Neisseria meningitidis serogroup W, Burkina Faso, 2012

Emerging Infectious Diseases

Volumn 20, Issue 3, 2014, Pages 394-399

  MacNeil, Jessica R ^a   Medah, Isaïe ^b   Koussoubé, Daouda ^b   Novak, Ryan T ^a   Cohn, Amanda C ^a   Diomandé, Fabien V K ^c   Yelbeogo, Denis ^b   Kambou, Jean Ludovic ^b   Tarbangdo, Tiga F ^b   Ouédraogo Traoré, Rasmata ^d   Sangaré, Lassana ^e   Hatcher, Cynthia ^a   Vuong, Jeni ^a   Mayer, Leonard W ^a   Djingarey, Mamoudou H ^c   Clark, Thomas A ^a   Messonnier, Nancy E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^c World Health Organization Ouagadougou   (Burkina Faso)

^d Centre Hospitalier Universitaire Pediatrique Charles de Gaulle   (Burkina Faso)

^e Centre Hospitalier Universitaire Yalgado   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BURKINA FASO; CHILD; CLASSIFICATION; GENETICS; GENOTYPE; HEALTH SURVEY; HISTORY; HUMAN; INCIDENCE; INFANT; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; NEWBORN; PRESCHOOL CHILD; SEROTYPE; YOUNG ADULT;

ADOLESCENT; BURKINA FASO; CHILD; CHILD, PRESCHOOL; GENOTYPE; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; POPULATION SURVEILLANCE; SEROGROUP; YOUNG ADULT;

EID: 84894244039     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2003.131407     Document Type: Article

References (27)

1. Lapeyssonnie L. Cerebrospinal meningitis in Africa [in French]. Bull World Health Organ. 1963;28(Suppl):1-114.
2. Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341-53. http://dx.doi. org/10.1016/S0035-9203(99)90106-2
3. Djingarey MNS, Preziosi MP. A 20-year retrospective analysis of epidemic meningitis surveillance data in Burkina Faso, Mali, and Niger. 16th International Pathogenic Neisseria Conference; 2008 Sep 7-12; Rotterdam, the Netherlands; 2008. p. P166 [cited 2013 Dec 27]. http://neisseria.org/ipnc/2008/abstracts_poster_ presentations_ipnc_2008.pdf
4. Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, et al. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine. 2012;30(Suppl 2):B40-5. http://dx.doi.org/10.1016/ j.vaccine.2011. 12.073
5. Novak RT, Kambou JL, Diomande FV, Tarbangdo TF, Ouedraogo-Traore R, Sangare L, et al. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis. 2012;12:757-64. http://dx.doi.org/10.1016/ S1473-3099(12)70168-8
6. Delrieu I, Yaro S, Tamekloe TA, Njanpop-Lafourcade BM, Tall H, Jaillard P, et al. Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS ONE. 2011;6:e19513. http://dx.doi.org/10.1371/journal.pone.0019513
7. Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis. 2003;9:665-71. http://dx.doi.org/10.3201/eid0906.020565
8. Issa M, Molling P, Unemo M, Backman A, Mosaad M, Sulaiman N, et al. Neisseria meningitidis serogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj in 2000. Scand J Infect Dis. 2003;35:230-3.
9. Matsika-Claquin MD, Perrocheau A, Taha MK, Levy-Bruhl D, Renault P, Alonso JM, et al. Meningococcal W135 infection epidemics associated with pilgrimage to Mecca in 2000 [in French]. Presse Med. 2001;30:1529-34.
10. Meningococcal meningitis. Wkly Epidemiol Rec. 2003;78:294-6.
11. Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis. 2006;43:817-22. http://dx.doi.org/10.1086/507339
12. Forgor AA, Leimkugel J, Hodgson A, Bugri A, Dangy JP, Gagneux S, et al. Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health. 2005;10:1229-34. http://dx.doi.org/10.1111/ j.1365-3156.2005.01520.x
13. Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, Jusot JF, et al. Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerg Infect Dis. 2010;16:1496-8. http://dx.doi.org/10.3201/ eid1609.100510
14. Massenet D, Inrombe J, Mevoula DE, Nicolas P. Serogroup W135 meningococcal meningitis, northern Cameroon, 2007-2008. Emerg Infect Dis. 2009;15:340-2. http://dx.doi.org/10.3201/ eid1502.080988
15. Meningococcal disease in countries of the African meningitis belt, 2012. Emerging needs and future perspectives. Wkly Epidemiol Rec. 2013;88:129-36.
16. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol. 2004;42:320-8. http://dx.doi.org/10.1128/ JCM.42.1.320-328.2004
17. World Health Organization. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. 2nd ed. Geneva: The Organization; 2011.
18. World Health Organization. Control of epidemic meningococcal disease. WHO practical guidelines. 2nd ed. Geneva: The Organization; 1998.
19. Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, et al. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol. 2003;41:1623-36. http://dx.doi.org/10.1128/JCM.41.4.1623-1636.2003
20. Leake JA, Kone ML, Yada AA, Barry LF, Traore G, Ware A, et al. Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bull World Health Organ. 2002;80:342-9.
21. Nathan N, Rose AM, Legros D, Tiendrebeogo SR, Bachy C, Bjorlow E, et al. Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis. 2007;13:920-3. http://dx.doi. org/10.3201/eid1306.060940
22. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis. 2002;185:1596-605. http://dx.doi.org/10.1086/340414
23. Kristiansen PA, Diomandé F, Ba AK, Sanou I, Ouédraogo AS, Ouédraogo R, et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2013;56:354-63. http://dx.doi.org/10.1093/ cid/cis892
24. Yaro S, Traoré Y, Tarnagda Z, Sangaré L, Njanpop Lafourcade BM, Drabo A, et al. Meningococcal carriage and immunity in western Burkina Faso, 2003. Vaccine. 2007;25(Suppl 1):A42-6. http://dx.doi.org/10.1016/j.vaccine.2007.04.039
25. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196:1346-54. http://dx.doi.org/10.1086/521626
26. Trotter CL, Ramsay ME, Gray S, Fox A, Kaczmarski E. No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. Lancet Infect Dis. 2006;6:616-7, author reply 7-8. http://dx.doi. org/10.1016/S1473-3099(06)70584-9
27. Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, et al. Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis. 2012;18:63-70. http://dx.doi.org/10.3201/eid1801.110901